We discovered that the methylation levels of SRCIN1 in lung cancer, colon cancer, esophageal cancer and uterine cancer samples from Taiwanese patients were not significantly different between tumor and normal tissues (Figure 3A). This evidence concerns the gene SRCIN1 and malignant colon neoplasm.